Vir Biotechnology, Inc.
Developing treatments for infectious diseases from an immunological perspective. Using technology platforms focused on antibodies, T cells, innate immunity, and siRNA, we are working to develop treatments for Hepatitis B virus, Influenza A, Severe Acute Respiratory Syndrome Coronavirus 2, HIV, and other diseases. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 587 |
Founded | 2016 |
Financials | |
|---|---|
Market Capitalization | 1.27B |
Revenue | 79.60M |
Operating Income | -621.01M |
Operating Margin | -780.18% |
Net Income | -539.44M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 5294 / 5373 |
Sector : Healthcare | 1130 / 1144 |
Industry : Biotechnology | 640 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2284 / 5565 |
Sector : Healthcare | 291 / 1182 |
Industry : Biotechnology | 111 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 5325 / 5436 |
Sector : Healthcare | 1143 / 1164 |
Industry : Biotechnology | 651 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 2850 / 5330 |
Sector : Healthcare | 292 / 1174 |
Industry : Biotechnology | 42 / 667 |